Stay updated on Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Sign up to get notified when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.

Latest updates to the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page
- ChecktodayChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check28 days agoChange DetectedA banner announces updates to NIH website terminology, including the transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.8%

- Check35 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check42 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check63 days agoChange DetectedThe record history now lists revision v3.7.0, replacing the previous v3.6.6. This indicates an update to the study record's version history.SummaryDifference0.1%

Stay in the know with updates to Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.